If you need more lookups,
subscriptions start at $34 USD/month.
Terrence Fullem Location
United States
Terrence Fullem Work
2026 -now Chief Executive Officer @
2022 -2026 President - US Business Operations @
2017 -2022 President @
2013 -2016 VP, Specialty Pharmaceuticals @
2008 -2012 VP, Commercial Development @
2007 -2008 VP, Portfolio Management and Marketing @
2003 -2006 General Manager, SSL and OTC @ Alpharma
1999 -2002 Strategy Consultant @ Mars & Co
1998 -1998 Corporate Finance Intern @
1995 -1997 Commercial Lines Underwriter @
Terrence Fullem Education
NYU Stern School of Business
MBA (Finance, Management & Marketing)
1997-1999
Colgate University
BA (Economics)
1989-1994
The Lawrenceville School 1985-1989
Terrence Fullem Skills
Competitive Analysis
Segmentation
Strategy
Mergers
Business Strategy
Financial Modeling
Pharmaceutical Industry
Strategic Planning
Market Analysis
Cross-functional Team Leadership
Market Research
Management Consulting
Biotechnology
Business Development
Management
Cross Functional Team Leadership
Portfolio Management
Microsoft Excel
Customer Service
Business Planning
Product Launch
Analytics
Marketing Strategy
Corporate Finance
Pricing
Due Diligence
Forecasting
Regulatory Affairs
Pharmaceutics
Product Development
Start Ups
Mergers and Acquisitions
Financial Analysis
Integration
Consulting
Project Management
Strategic Partnerships
Product Management
Finance
Marketing
Microsoft Office
Social Media
Terrence Fullem Summary
Terrence Fullem, based in United States, is currently a Chief Executive Officer at AdvaGen Pharma. Terrence Fullem brings experience from previous roles at Strides Pharma Inc., Cadista Pharmaceuticals, Perrigo and Actavis. Terrence Fullem holds a 1997 - 1999 MBA in Finance, Management & Marketing @ NYU Stern School of Business. With a robust skill set that includes Competitive Analysis, Segmentation, Strategy, Mergers, Business Strategy and more. Terrence Fullem has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Terrence Fullem?
Find contact details for 700 million professionals.